The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry
Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.
Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis
Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: longitudinal data from the UK CF Registry
